Literature DB >> 11857776

Effect of peroxisome proliferators on the methylation and protein level of the c-myc protooncogene in B6C3F1 mice liver.

Rongrong Ge1, Lianhui Tao, Paula M Kramer, Michael L Cunningham, Michael A Pereira.   

Abstract

Peroxisome proliferators in general are nongenotoxic mouse liver carcinogens for which DNA hypomethylation and altered gene expression are proposed mechanisms. Therefore, the peroxisome proliferators 2,4-dichlorophenoxyacetic acid (2,4-D), dibutyl phthalate (DBP), gemfibrozil, and Wy-14,643 were evaluated for the ability to alter the methylation and expression of the c-myc protooncogene. Male B6C3F1 mice were administered for 6 days in their diet Wy-14,643 (5-500 ppm), 2,4-D (1,680 ppm), DBP (20,000 ppm), or gemfibrozil (8,000 ppm). All four peroxisome proliferators caused hypomethylation of the c-myc gene in the liver. Wy-14,643 appeared to be the most efficacious with a threshold between 10 and 50 ppm. The level of the c-myc protein was increased by Wy-14,643, but not the other peroxisome proliferators. When female B6C3F1 mice received a two-thirds partially hepatectomy and 16 h later were administered 50 mg/kg Wy-14,643 by gavage, hypomethylation of the gene occurred 24 h later. Hypomethylation was not found in mice that received Wy-14,643 following a sham operation. Hypomethylation of the c-myc gene within 24 h of administering Wy-14,643 after a partial hepatectomy but not after a sham operation supports the hypothesis that the peroxisome proliferators prevent methylation of hemimethylated sites formed by DNA replication. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11857776     DOI: 10.1002/jbt.10019

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  3 in total

1.  Effects of the PPARα Agonist and Widely Used Antihyperlipidemic Drug Gemfibrozil on Hepatic Toxicity and Lipid Metabolism.

Authors:  Michael L Cunningham; Bradley J Collins; Milton R Hejtmancik; Ronald A Herbert; Gregory S Travlos; Molly K Vallant; Matthew D Stout
Journal:  PPAR Res       Date:  2010-10-04       Impact factor: 4.964

Review 2.  Key issues in the modes of action and effects of trichloroethylene metabolites for liver and kidney tumorigenesis.

Authors:  Jane C Caldwell; Nagalakshmi Keshava
Journal:  Environ Health Perspect       Date:  2006-09       Impact factor: 9.031

3.  Tissue-specific changes in Srebf1 and Srebf2 expression and DNA methylation with perinatal phthalate exposure.

Authors:  Laura Moody; Diego Hernández-Saavedra; Daniel G Kougias; Hong Chen; Janice M Juraska; Yuan-Xiang Pan
Journal:  Environ Epigenet       Date:  2019-06-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.